Immunic Inc (IMUX)
1.38
+0.05
(+3.76%)
USD |
NASDAQ |
May 03, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Immunic Net Income (TTM): -93.61M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -93.61M |
| September 30, 2023 | -128.51M |
| June 30, 2023 | -126.97M |
| March 31, 2023 | -124.87M |
| December 31, 2022 | -120.41M |
| September 30, 2022 | -85.12M |
| June 30, 2022 | -83.19M |
| March 31, 2022 | -79.22M |
| December 31, 2021 | -92.94M |
| September 30, 2021 | -82.92M |
| June 30, 2021 | -76.54M |
| March 31, 2021 | -70.06M |
| December 31, 2020 | -44.02M |
| September 30, 2020 | -40.55M |
| June 30, 2020 | -35.85M |
| March 31, 2020 | -39.11M |
| December 31, 2019 | -34.93M |
| September 30, 2019 | -29.71M |
| June 30, 2019 | -33.43M |
| March 31, 2019 | -31.40M |
| December 31, 2018 | -41.48M |
| September 30, 2018 | -53.60M |
| Date | Value |
|---|---|
| June 30, 2018 | -54.14M |
| March 31, 2018 | -53.86M |
| December 31, 2017 | -52.08M |
| September 30, 2017 | -49.22M |
| June 30, 2017 | -46.92M |
| March 31, 2017 | -43.98M |
| December 31, 2016 | -40.97M |
| September 30, 2016 | -39.09M |
| June 30, 2016 | -41.22M |
| March 31, 2016 | -46.85M |
| December 31, 2015 | -52.02M |
| September 30, 2015 | -56.12M |
| June 30, 2015 | -56.62M |
| March 31, 2015 | -51.68M |
| December 31, 2014 | -47.67M |
| September 30, 2014 | -43.95M |
| June 30, 2014 | -38.13M |
| March 31, 2014 | -34.11M |
| December 31, 2013 | -32.72M |
| September 30, 2013 | -22.87M |
| June 30, 2013 | -18.56M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-128.51M
Minimum
Sep 2023
-29.71M
Maximum
Sep 2019
-74.84M
Average
-79.22M
Median
Mar 2022
Net Income (TTM) Benchmarks
| Kymera Therapeutics Inc | -146.96M |
| Insmed Inc | -749.57M |
| SELLAS Life Sciences Group Inc | -37.34M |
| Skye Bioscience Inc | -37.64M |
| Leap Therapeutics Inc | -81.41M |